The colonic polyphenol catabolite dihydroferulic acid (DHFA) regulates macrophages activated by oxidized LDL, 7-ketocholesterol, and LPS switching from pro- to anti-inflammatory mediators

• Published in: Food & function Vol. 15; no. 20; pp. 10399 - 10413
• Main Authors: Lara-Guzmán, Oscar J, Arango-González, Ángela, Rivera, Diego A, Muñoz-Durango, Katalina, Sierra, Jelver A
• Format: Journal Article
• Language: English
• Published: England Royal Society of Chemistry 14.10.2024
• Subjects: Anti-inflammatory agents; Arteriosclerosis; Atherosclerosis; Catabolites; CD36 antigen; Cell activation; Cell differentiation; Chlorogenic acid; Cholesterol; Coffee; Inflammasomes; Inflammation; Interleukin 10; Intestinal microflora; Lipopolysaccharides; Low density lipoprotein; Macrophages; Oxidative stress; Phenolic acids; Phenols; Phenotypes; Reactive oxygen species; Tumor necrosis factor-α
• ISSN: 2042-6496; 2042-650X; 2042-650X
• DOI: 10.1039/d4fo02114b

Macrophage activation plays a central role in the development of atherosclerotic plaques. Interaction with oxidized low-density lipoprotein (oxLDL) leads to macrophage differentiation into foam cells and oxylipin production, contributing to plaque formation. 7-Ketocholesterol (7KC) is an oxidative byproduct of cholesterol found in oxLDL particles and is considered a factor contributing to plaque progression. During atherosclerotic lesion regression or stabilization, macrophages undergo a transformation from a pro-inflammatory phenotype to a reparative anti-inflammatory state. Interleukin-10 (IL-10) and PGE appear to be crucial in resolving both acute and chronic inflammatory processes. After coffee consumption, the gut microbiota processes non-absorbed chlorogenic acids producing various lower size phenolic acids. These colonic catabolites, including dihydroferulic acid (DHFA), may exert various local and systemic effects. We focused on DHFA's impact on inflammation and oxidative stress in THP-1 macrophages exposed to oxLDL, 7KC, and lipopolysaccharides (LPS). Our findings reveal that DHFA inhibits the release of several pro-inflammatory mediators induced by LPS in macrophages, such as CCL-2, CCL-3, CCL-5, TNF-α, IL-6, and IL-17. Furthermore, DHFA reduces IL-18 and IL-1β secretion in an inflammasome-like model. DHFA demonstrated additional benefits: it decreased oxLDL uptake and CD36 expression induced by oxLDL, regulated reactive oxygen species (ROS) and 8-isoprostane secretion (indicating oxidative stress modulation), and selectively increased IL-10 and PGE levels in the presence of inflammatory stimuli (LPS and 7KC). Finally, our study highlights the pivotal role of PGE in foam cell inhibition and inflammation regulation within activated macrophages. This study highlights DHFA's potential as an antioxidant and anti-inflammatory agent, particularly due to its ability to induce PGE and IL-10.